review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | F J Ten Cate | |
M L Geleijnse | |||
C van der Lee | |||
M J Kofflard | |||
P2860 | cites work | Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle | Q24324826 |
Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy | Q28236892 | ||
Sudden death due to troponin T mutations | Q28305351 | ||
Prognosis and mortality of hypertrophic obstructive cardiomyopathy | Q33170393 | ||
Molecular genetics and pathogenesis of hypertrophic cardiomyopathy | Q34021080 | ||
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults | Q34058337 | ||
Hypertrophic cardiomyopathy: a systematic review | Q34117625 | ||
New insights into the pathology of inherited cardiomyopathy | Q35583633 | ||
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair | Q35679277 | ||
Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene | Q35938322 | ||
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis | Q36782521 | ||
Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy | Q36915274 | ||
Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy | Q40467490 | ||
Molecular basis of familial cardiomyopathies | Q40559439 | ||
Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy | Q40599706 | ||
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy | Q47879338 | ||
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy | Q47879851 | ||
Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene | Q47957734 | ||
Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy | Q48020405 | ||
Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients | Q67019025 | ||
Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy | Q68860551 | ||
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy | Q70048652 | ||
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy | Q70658788 | ||
Prognosis in hypertrophic cardiomyopathy | Q70795347 | ||
Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients | Q71827470 | ||
Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy | Q72773598 | ||
Apical hypertrophic cardiomyopathy developing at a relatively advanced age | Q73635743 | ||
Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes | Q74315525 | ||
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease | Q74522881 | ||
Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis | Q74682836 | ||
AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy | Q77580246 | ||
The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands | Q79175295 | ||
Hypertrophic cardiomyopathy | Q80172333 | ||
P433 | issue | 12 | |
P921 | main subject | hypertrophic cardiomyopathy | Q1364270 |
P304 | page(s) | 452-460 | |
P577 | publication date | 2005-12-01 | |
P1433 | published in | Netherlands Heart Journal | Q2146163 |
P1476 | title | Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment | |
P478 | volume | 13 |